Page last updated: 2024-10-29

ifosfamide and Cancer of the Fallopian Tube

ifosfamide has been researched along with Cancer of the Fallopian Tube in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Ifosfamide has been shown to possess modest activity in patients with platinum/cyclophosphamide refractory ovarian cancer."2.69Phase 2 trial of single agent ifosfamide/mesna in patients with platinum/paclitaxel refractory ovarian cancer who have not previously been treated with an alkylating agent. ( Belinson, J; Hurteau, J; Kennedy, A; Kulp, B; Markman, M; Peterson, G; Sutton, G; Webster, K, 1998)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Markman, M1
Kennedy, A1
Sutton, G1
Hurteau, J1
Webster, K1
Peterson, G1
Kulp, B1
Belinson, J1
Halligan, AW1
McGuinness, EP1

Trials

1 trial available for ifosfamide and Cancer of the Fallopian Tube

ArticleYear
Phase 2 trial of single agent ifosfamide/mesna in patients with platinum/paclitaxel refractory ovarian cancer who have not previously been treated with an alkylating agent.
    Gynecologic oncology, 1998, Volume: 70, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Carboplatin; Cisplatin; Cysta

1998

Other Studies

1 other study available for ifosfamide and Cancer of the Fallopian Tube

ArticleYear
Malignant fibrous histiocytoma of the fallopian tube.
    British journal of obstetrics and gynaecology, 1990, Volume: 97, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Fallopian Tube Neoplasms; Female; Histio

1990